Live Breaking News & Updates on Granulin Mutations

Stay updated with breaking news from Granulin mutations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Passage Bio : Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline - Form 8-K

Passage Bio Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline

-

. | January 10, 2022 ....

University Of Pennsylvania , United States , Gwen Fisher , Stuart Henderson , Bruce Goldsmith , Exchange Commission , Key Anticipated Company , Clinical Development Goals To Advance Robust , University Of Pennsylvania Gene Therapy Program , Gene Therapy Program At Penn , Passage Bio Inc , Passage Bio Announces , Clinical Development Goals , Advance Robust , Investigational New Drug , Princeton West Innovation Campus , Gene Therapy Program , Passage Bio , Anticipated Company Highlights , Frontotemporal Dementia , Granulin Mutations , Krabbe Disease , Charcot Marie Tooth Type , Private Securities Litigation Reform Act , Risk Factors , Bio Investors ,